ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Teva expects FDA preapproval inspection of troubled Celltrion plant this year
May 07, 2018Teva said in its first-quarter earnings report that it expects an FDA pre-approval inspection in the coming months of the plant where its partner Celltrion produces the API for Teva's migraine treatment fremanezumab. Wall Street speculation had focused
Pharma Sources Insight January 2025
